Aytu Biopharma (AYTU) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to -$30.0 million.
- Aytu Biopharma's Enterprise Value fell 4719.58% to -$30.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$30.0 million, marking a year-over-year decrease of 4719.58%. This contributed to the annual value of -$31.0 million for FY2025, which is 5471.36% down from last year.
- According to the latest figures from Q4 2025, Aytu Biopharma's Enterprise Value is -$30.0 million, which was down 4719.58% from -$32.6 million recorded in Q3 2025.
- In the past 5 years, Aytu Biopharma's Enterprise Value ranged from a high of -$18.2 million in Q1 2025 and a low of -$50.2 million during Q2 2021
- In the last 5 years, Aytu Biopharma's Enterprise Value had a median value of -$21.7 million in 2023 and averaged -$26.8 million.
- Per our database at Business Quant, Aytu Biopharma's Enterprise Value skyrocketed by 6139.81% in 2022 and then tumbled by 6227.37% in 2025.
- Over the past 5 years, Aytu Biopharma's Enterprise Value (Quarter) stood at -$35.3 million in 2021, then soared by 44.72% to -$19.5 million in 2022, then decreased by 0.14% to -$19.5 million in 2023, then dropped by 4.45% to -$20.4 million in 2024, then crashed by 47.2% to -$30.0 million in 2025.
- Its last three reported values are -$30.0 million in Q4 2025, -$32.6 million for Q3 2025, and -$31.0 million during Q2 2025.